Sodium thiosulfate: Interim Phase III data

Interim data from the open-label, U.K. Phase III SIOPEL 6 trial in 109 newly diagnosed patients receiving cisplatin monotherapy for standard risk hepatoblastoma showed that 20 g/m 2 IV STS plus cispla...